Search hospitals > Kansas > Wichita

Wichita NCI Community Oncology Research Program

Claim this profile
Wichita, Kansas 67214
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
Conducts research for Ovarian Cancer
96 reported clinical trials
2 medical researchers
Photo of Wichita NCI Community Oncology Research Program in WichitaPhoto of Wichita NCI Community Oncology Research Program in WichitaPhoto of Wichita NCI Community Oncology Research Program in Wichita

Summary

Wichita NCI Community Oncology Research Program is a medical facility located in Wichita, Kansas. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Adenocarcinoma, Ovarian Cancer and other specialties. Wichita NCI Community Oncology Research Program is involved with conducting 96 clinical trials across 258 conditions. There are 2 research doctors associated with this hospital, such as Shaker Dakhil, M.D. and Paul Murphy, MD.

Area of expertise

1Cancer
Global Leader
Wichita NCI Community Oncology Research Program has run 41 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Wichita NCI Community Oncology Research Program has run 20 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
HER2 positive

Top PIs

Clinical Trials running at Wichita NCI Community Oncology Research Program

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Wichita NCI Community Oncology Research Program?
Wichita NCI Community Oncology Research Program is a medical facility located in Wichita, Kansas. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Adenocarcinoma, Ovarian Cancer and other specialties. Wichita NCI Community Oncology Research Program is involved with conducting 96 clinical trials across 258 conditions. There are 2 research doctors associated with this hospital, such as Shaker Dakhil, M.D. and Paul Murphy, MD.